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Abstract 
Due to their extraordinary physical and chemical properties carbon nanotubes reveal 
a promising potential as biomedical agents for heating, temperature sensoring and 
drug delivery on the cellular level. Filling carbon nanotubes with tailored materials 
realises nanoscaled containers in which the active content is encapsulated by a 
protecting carbon shell. We describe different synthesis routes and show the 
structural and magnetic properties of carbon nanotubes. In particular, the filling with 
magnetic materials offers the potential for hyperthermia applications while the 
insertion of NMR active substances allows the usage as markers and sensors. The 
potential of carbon nanotubes for biomedical applications is highlighted by 
hyperthermia studies which prove their applicability for local in-situ heating. In 
addition we have shown that a non-invasive temperature control by virtue of a 
carbon-wrapped nanoscaled thermometer and filling with anti-cancer drugs is 
possible.  
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Strong adverse effects on the healthy tissue in the vicinity of a tumour are a major 
drawback in current cancer therapies. One innovative technological approach to 
solve this problem focuses on therapies on the cellular level by applying intracellular 
probes, i.e. the transfer of nano-sized biocompatible devices into the cells. Most 
promising materials in this regard are magnetic nanoparticles which can be 
addressed by external magnetic fields. A great advantage of magnetic fields is their 
biocompatibility, i.e. they penetrate tissue non-invasively and without known adverse 
effects, and their weak interaction with organic matter so that deep layers of (human) 
tissue can be reached. In particular, magnetic nanoparticles can be localized in deep 
tissue, external static magnetic fields can fix them at a precise position, gradient 
fields can move them and alternating (AC) fields lead to local heating. The latter can 
be utilized for hyperthermia applications which is shown e.g. by the use of 
superparamagnetic nanoparticles for magnetic fluid hyperthermia [1] Much of the 
current research is focused on iron oxide nanoparticles which have proven their 
feasibility in animal experiments [2,3] and are now under clinical trials [4]. Other 
magnets usually present limitations due to biocompatibility issues, since most of 
them contain potentially toxic elements. 
 
Due to its particular magnetic properties, i.e. large anisotropy and saturation 
magnetisation, metallic iron could generate heat more efficiently in comparison to 
iron oxides since various mechanisms yield dissipative effects such as domain wall 
motion etc. [5]. In practice, higher heating efficiency means that less nanoscaled 
material would have to be introduced into the biological system in order to achieve 
the targeted hyperthermia effect. The use of nanoparticles made of iron, however, is 
hindered by the fact that oxidation in ambient or biological conditions has to be 
avoided. A promising way to overcome this problem appears to be the coating of the 
iron with a carbon shell by insertion of the material inside of carbon nanotubes (CNT) 
and thereby protecting the biological environment and the filling material against 
each other. Degradation of filling materials is avoided and their potential toxicity and 
adverse effects are suppressed so that CNT provide a smart carrier system on the 
nanometer scale. 
 
A targeted hyperthermia therapy using iron filled CNT and, in general, utilisation of 
tailored carbon nanotube based biomedical agents for therapeutic and diagnostic 
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purposes can hence be envisioned which will be detailed in the following sections. 
After introducing some basic properties of CNT, a short review of 
biofunctionalisation, biocompatibility and toxicity aspects is provided. The synthesis 
of iron filled CNT as well as magnetic and hyperthermia studies are discussed. 
Adding additional material such as a thermometer in Fe-filled CNT increases the 
potential of CNT as hyperthermia inducing agents since simultaneous local heating 
and temperature control might be feasible. Moreover, the container feature of CNT 
offers the step beyond the controlled heat treatment but also suggests the additional 
local release of therapeutics. 
 
2. Biocompatibility and Toxicity 
CNT are hollow carbon structures with one or more walls, a small diameter on the 
nanometre scale and a large length in comparison. Their mechanically and 
chemically stable carbon shells can be opened, filled and closed again without losing 
their stability. Experiences in filling CNT range back to their discovery in 1991 [6]. 
Since then, extensive work has been performed to synthesise CNT and to 
functionalise them both exohedrally, i.e. by attaching functional elements to the outer 
shell, and endohedrally by filling with various materials. CNT can be filled with 
metals, semiconductors, salts, organic materials, fullerenes, etc., either during the 
synthesis process or through subsequent opening, filling, and closing of the CNT. In 
particular, ferromagnetic materials such as Fe, Ni, and Co can be encapsulated 
which is relevant to hyperthermia applications. Introducing fluorescent markers offers 
a route for visualising CNT [7], which is also possible by exohedral functionalisation 
[8,9]. The container feature of CNT allows, in principle, simultaneous filling of CNT 
with different materials thereby combining multiple functionalities in one kind of 
carrier (Fig. 1). In this way CNT provide a smart carrier system on the nanometer 
scale which can be filled with tailored materials to address specific purposes. The 
container function is underlined by recent model calculations for encapsulation of the 
anticancer drug cisplatin. Interestingly, all three orientations of cisplatin might be 
transferred into a CNT if its minimum radius is at least 4.785 Å while the maximum 
uptake occurs for radii of approximately 5.3 Å. These results hence suggest that 
multi-walled CNT with a relatively large inner diameter are particularly appropriate for 
drug delivery of common therapeutics like cisplatin or carboplatin [10]. 
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Beyond the shielding effect against a biological environment, the carbon coating 
offers an interface for further exohedral functionalisation with suitable (bio-) 
molecules. A major task of such functionalisation is the stable dispersion of the 
nanoparticles in aqueous media which still is a major challenge. Both non-covalent 
and covalent modification strategies can be applied among which the former 
preserve the pristine CNT structure while covalent modification introduces partial 
damage of the outer wall but in general yields better dispersion. Dispersion becomes 
even more crucial if ferromagnetically filled CNT are envisaged which exhibit an 
increased tendency to agglomerate due to magnetic interactions. In addition, 
exohedral functionalisation is needed to get the highly symmetric carbon structures 
compatible to actual biological environments. Nowadays, also functionalisation 
aiming to perform dynamic tasks such as target recognition, target transformation, 
transport, or electrical conduction in the living cell is addressed. These functions can 
be provided by biomolecules, like DNA and enzyme proteins. Importantly for any 
therapeutical or biomedical usage, functionalised CNT can cross effectively biological 
barriers such as the cell membrane and penetrate the individual cell. Recently, it was 
shown that DNA wrapped SWNT were enveloped by cancer cells and they were 
used to deliver a lethal dose of microwave radiation to the cancer cells [11]. In 
contrast to such a wrapping CNT with biomolecules, any chemical exohedral 
functionalisation needed to improve the biocompatibility of CNT will structurally 
perturbate the external wall which however in the case of multi-walled CNT does not 
affect the overall carbon shielding. A variety of methods exist for the exohedral 
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Fig. 1: Sketch of a filled carbon nanotube serving as multi-functional container for in-
vivo applications. A ferromagnet can induce heat in AC magnetic fields and a 
material with strongly temperature dependent nuclear magnetic resonance (NMR) 
signal might serve as a thermometer. Additional drug delivery can be envisaged. 
Exohedral functionalisation to achieve biocompatibility is sketched. Note, that single-
walled as well as multi-walled CNT can be realised. 
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functionalization of carbon nanotubes [12,13], some of which have been successfully 
applied for the conjugation of proteins, drugs and fluorescent dyes [14,15,16,17] and 
active tumor targeting in-vivo [18]. Successful biofunctionalisation is e.g. 
demonstrated by Pantarotto et al. who observed that functionalized CNT can cross 
the cell membrane and accumulate in the cytoplasm or reach the nucleus without 
being toxic for the cell [15]. Soluble CNT can be coupled with amino acids and 
bioactive peptides [19] for further derivatization. It was also shown that stable 
complex formation of CNT and cationic lipid may accelerate the delivery of 
nanotubes into the bladder cancer human cells [20]. For the actual mechanism of 
internalization, i.e. endocytosis or phagocytosis, which has been discussed 
contradictorily, the actual morphology of the CNT seems to be crucial [14,15,21]. 
 
Despite various industrial applications of CNT and their large scale synthesis only 
little is known about the interaction of CNT with biological environments. CNT and 
other nanomaterials when placed in contact with human (or other mammalian) body 
fluids and tissues are recognised by the immune system complement proteins, and 
may also interact with other systems, such as coagulation proteins and cell-surface 
proteins. Binding of complement proteins activates the complement system via both 
classical and alternative pathways and results in strong binding of several 
complement proteins to the CNT [22]. Such complement activation influences 
subsequent interaction of the CNT with cells and tissues and is a predictor of 
potential toxicity in animal models. Salvador-Morales et al. report that such protein 
binding to CNT is highly selective. In particular, fibrinogen and apolipoproteins were 
the proteins that bound to CNT in greatest quantity. Among proteins contained in 
lung surfactant, SP-A and SP-D selectively bind to CNT so that chronic level 
exposure may result in sequestration these proteins [23]. 
 
Although a variety of toxicity studies has been published (for recent reviews see e.g. 
[24,25]), no clear picture evolves for CNT in general. This is e.g. illustrated by 
contrasting in-vitro studies showing CNT to be safe [26,27] or to induce significant 
toxic effects [28,29,30]. One reason for this ambiguity is the fact that – similar to 
other nanoparticles – a large number of specific factors govern the toxicity of CNT 
such as their shape and size (diameter, length), the number of shells (single- or 
multi-walled CNT), agglomeration state and surface chemistry [31]. In particular, the 
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concentration of CNT is not necessarily a main parameter. On the other hand, 
ambiguity also results from a lack of standardisation and of thorough characterisation 
of, e.g., defects of the outer shell or potentially toxic contaminants. Such non-carbon 
material originating from the synthesis process of pristine empty CNT might amount 
to 5-10% of the total mass. This presumably accounts for much of the reported 
differences so that details of synthesis, choice of catalyst particles, washing 
procedures and dispersion methods have to be considered thoroughly.  
 
In the following we hence concentrate on multi-walled Fe-filled CNT which synthesis 
and properties are described in §3 and §4. We recall the feasibility of an efficient 
delivery of Fe-filled CNT into human cancer cell lines which has been shown in cell 
culture experiments [20]. A pre-treatment of Fe-filled CNT with cationic lipid was 
found to cause a qualitative delivery of the complexes into the cytoplasm but not into 
the nucleus. A recent study on cytotoxic effects of Fe-filled CNT in-vitro addressed 
metabolic activity, cell proliferation, apoptosis and cell cycle distribution of a 
malignant (PC-3) and a non malignant (fibroblasts) cell lineage. The data imply that 
CNT strongly associate with cells within a short incubation period. The presence of 
CNT in cells did not pose any significant toxic effect [32]. This observation is 
corroborated by an animal study on mice which indicated no remarkable toxic or 
adverse effects over a period of 440 days after the intraperitoneal or intravenous 
injection of pristine Fe-filled CNT. In particular, based on TEM and histological 
analyses after 6 weeks Mönch et al. [33] report the absence of any indication on 
inflammation. In one case, CNT have been administered up to a total of >1g Fe-filled 
MWCNTs/kg body weight over a period of 3 months. Interestingly, in agreement with 
the fact that pristine CNT were used, large agglomerates have been observed in 
various organs in case of the intravenous treatment. However, such agglomerates 
seem to have no drastic effects. All animals survived for more than one year and 
showed no abnormalities in behaviour or weight suggesting a general 
biocompatibility of the CNT for the applied doses. 
 
The long-term absence of significant toxicity effects in the mentioned animal study 
also implies the expected insignificant degradation of CNT in the biological 
environment. Regarding their fate in-vivo, excretion in feces and urine has been 
reported after injection of empty CNT injected intravenously or intraperitonally in mice 
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[34,35]. Studies on the biodistribution and translocation pathways of empty CNT in 
mice, however, indicate accumulation predominately in liver and retain for long time 
while low acute toxicity is confirmed [36]. 
 
3. Synthesis of Ferromagnetic Filled Multi-walled Carbon Nanotubes 
Encapsulation of iron nanowires in CNT realises highly anisotropic ferromagnetic 
nanoparticles which are discussed for a wide range of potential applications [37]. 
Among a variety of methods to synthesize these filled carbon structures such as arc 
discharge [38] and laser ablation [39], the chemical vapour deposition (CVD) is 
applied when a high yield uniform multi-walled CNT is aimed [40].  
A suitable method for synthesizing CNT filled with metals as Fe, Co or Ni is the so-
called ‘‘in situ method’’, a special CVD-method, in which the formation of CNT and 
their filling with ferromagnetic elements or compounds take place simultaneously. 
Here, relevant precursors are needed, which e.g. provide as well iron for the filling as 
carbon for the shells. The most common precursors are metallocenes [Me(C5H5)2; 
Me = Fe, Co, Ni] which supply a large scale of well-defined multi-walled (MW) CNT 
with a high filling yield (about 50 %) of the ferromagnetic material. Many groups 
world-wide use this method in different equipments. Sen et al. reported the first 
experimental results for the synthesis of ferromagnetic MWCNT [41]. In a typical 
experiment the ferromagnetically filled MWCNT are grown in a quartz tube reactor 
inside a dual zone furnace system. The main parameters of the deposition process 
are the sublimation temperature of the metallocene in the first furnace, the gas flow 
rate, and the temperature of the second hot furnace zone where the pyrolysis of 
metallocene and the deposition of filled tubes take place. CNT are formed on 
oxidized silicon substrates uncoated or coated (2 nm layer of different materials such 
as Fe, Co and Permalloy) placed inside the reaction zone. In this case they grow in 
perpendicular alignment to the substrate surface. Much more nanotubes are formed 
on the wall of the quartz tube reactor (which is a mixture of bundles of well-aligned 
Fe-filled MWCNT) [42,43, 44, 45].  
 
An additional technique is the liquid source CVD (LS-CVD) [40]. This method is 
characterized by a constant and reproducible transport of the precursor. The 
metallocene, especially the ferrocene, is dissolved in cyclopentane and dropped on 
the moving band continuously. In the first part of the system the solvent is vaporized 
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and only the ferrocene is transferred into the reactor at a defined temperature and 
with a constant transport velocity. In the deposition reactor a second moving band, 
populated with precoated substrates is positioned. This LSCVD method is highly 
suited for the continuous production of defined ferromagnetically filled CNT. Wang et 
al. have synthesized Fe-filled CNT with a high filling ratio by using ferrocene and 
dichlorbenzene as precursor [46]. This solution is injected through a nozzle directly 
into the reactor so that a spontaneous decomposition reaction occurs. Pichot et al. 
applied an aerosol assisted CVD (AA-CVD) [47] device to produce Fe filled CNT. 
Ultrasonicating a solution of ferrocene in cyclohexane produced an aerosol, which 
was then carried for 15 min by an argon flow through a quartz reactor placed in a 
tubular furnace at 850 °C. Eventually, MWCNT carpets were deposited on the 
reactor walls [48].  
 
Filled CNT can be also synthesised by a post-synthesis method. This technique 
includes (1) the synthesis of empty CNT, (2) the opening of their ends, (3) a filling 
step with various materials (metals, salts, therapeutics) and (4) the closing step of 
the filled CNT. The opening procedure is mostly done by well established wet-
chemistry techniques [49] or by oxidation in air [50, 51]. The easiest way to 
incorporate the material into the open ended CNT is over a gasphase reaction where 
the CNT and the filling material are inserted together into glass ampoules sealed 
under vacuum and heated beyond the sublimation temperature of the filling material 
[52, 53]. But also a wet chemical approach can be applied where capillarity is the 
driving force [54,55],49. The closure of the openended and filled CNT can be realised 
by a redeposition with a polymer or other carbon-containing phases [56]. Various 
techniques such as transmission electron microscopy and X-ray diffraction 
demonstrate the successful synthesis of Fe-filled CNT by our CVD technique 
[40,43,42,57,58,59,60]. E.g., the cross section shown in Fig. 2 clearly indicated the 
single crystalline Fe filling as well as the carbon shell.  
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The length of CNT is in the micrometer range and outer diameters vary from 20-80 
nm. The Fe-filling is discontinuous and consists of iron nanowires with a filling yield 
of ~50%. Interestingly, by x-ray diffraction the existence of the body-centered 
structure (α-Fe), the face-centered cubic structure (γ-Fe) and in very low 
concentration also of Fe3C could be verified. For a hyperthermia application a high 
yield of the ferromagnetic α-Fe is requested. By changing details of the synthesis 
process the relative yields of the different Fe-phases can be adjusted. The rate of the 
ferromagnetic α-Fe is increased by an annealing process below the temperature of 
the phase transition of γ-Fe to α-Fe which indeed yields a larger saturation 
magnetization [59]. To get exact information about the morphology of the iron filled 
CNT (γ-Fe/α-Fe ratio), the 57Fe Mössbauer spectroscopy is an appropriate method. 
Transmission Mössbauer spectroscopy (TMS) and backscattered conversion 
electron Mössbauer spectroscopy (CEMS) were applied in order to distinguish 
different Fe phases and their spatial distribution within the whole sample and along 
the tubes’ height by the group of Ruskov. A characterization (on a large spatial scale) 
of the aligned CNT samples was performed by obtaining TMS spectra for selected 
spots positioned at different locations of the sample. While the total Fe content 
changes considerably from one location to another, the γ-Fe/α-Fe phase ratio is 
constant onto a relatively large area. Using TMS and CEMS for all aligned Fe-
MWCNT samples it is also shown that along the CNT axes, going to the top of the 
nanotube the relative content of the γ-Fe phase increases. Going to the opposite 
direction, i.e., towards the silicon substrate, the relative content of the Fe3C phase 
increases [61]. 
   
 
Fig. 2: Typical SEM and TEM images of well-aligned iron filled multi-walled carbon 
nanotubes synthesised by LS-CV. 
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4. Magnetic properties and hyperthermia feasibility 
Various studies have shown that, independently of the synthesis technique, the 
carbon encapsulated iron is efficiently protected by the surrounding shells and its 
magnetic properties are retained. Often, magnetic characterisation studies have 
been performed for CNT fixed to a SiO2 substrate. For such studies, Fe-CNT are 
grown directly on the substrate so that a rather dense coating of well aligned 
nanowires is studied. For such aligned Fe-filled CNT, uniaxial magnetic anisotropy is 
reported with the easy magnetic axis being parallel to the CNT axis. The anisotropy 
can straightforwardly attributed to the shape anisotropy of the magnetic nanowires. 
However, depending on the alignment [43] and density of CNT on the substrate 
magnetic dipole-dipole interactions between the Fe-cores have to be considered, too. 
Interestingly, enhanced magnetic coercive fields of HC >100 mT are observed in such 
ensembles of Fe-filled CNT at room temperature [37,43] which significantly exceed 
the value HC =9*10-3 mT observed in bulk Fe. The more representative data for 
biomedical applications are achieved by powder measurements. Here, depending on 
the filling ratio, diameter, etc. coercive fields in the range of HC ~ 20-50 mT have 
been found. In a recent study the magnetisation of cells dried after incubation with 
Fe-filled CNT exhibited a critical field of similar size (~23 mT) [33].  
 
Magnetic coercivity is even more reduced when the magnetisation is measured in a 
living cell culture [32]. For such a study, 2*105 PC-3 cells were incubated with 
50µg/ml of Fe-filled CNT. After an incubation period of 4h, the cells were washed two 
times with PBS, trypsinized and centrifuged at 4oC. This procedure in total yielded 
approximately 1*106 cells which were resuspended in 100µl for media and 
measured, at 4oC, in a maximum applied field of H = 0.5T. Interestingly, the data 
imply only a vanishing coercivity of HC ~ (2±2) Oe. 
 
The magnetisation data suggest the feasibility of Fe-filled CNT for by applying an 
alternating (AC) magnetic field (see e.g. [62]). The heating effect is based on the 
physical principle that applied AC magnetic fields induce magnetisation loops. If 
these loops are not completely reversible (e.g. in the case of ferromagnetic particles 
or for superparamagnetic particles below the blocking temperature), magnetic energy 
is transformed into heat. We mention that residual ferromagnetic catalyst particles 
appear in most synthesis processes which provide superparamagnetism in CNT (e.g. 
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[63]). Another route to superparamagnetic CNT employs the insertion of Gd ions to 
form Gadonanotubes [64]. 
 
There are various physical mechanisms which yield non-reversible loops, i.e. which 
are related to magnetic dissipation processes, and it should be emphasized that in 
the case of Fe-filled CNT the mechanism has not yet been identified. In general, 
different processes will be related to different energy scales and resonance 
frequencies, so that the filling material, its size and its shape have a significant effect 
on the heating properties. For example there will be strong differences between the 
case of single-domain particles, where the magnetisation process competes with 
shape and crystal anisotropies, and the motion of domain walls in multi-domain 
particles. 
 
The feasibility of Fe-filled CNT for hyperthermia has been demonstrated by a 
calorimetric study in AC magnetic fields. Our test device consists of a high-frequency 
generator with an impedance matching network and the magnetic coil system. 
Water-cooled copper tubes are wound into a coil system (e.g., 4–10 turns, diameter 
of bore 20–100mm) in which the sample is placed. Temperature is controlled by a 
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Fig. 3: Specific absorption rate SARFe of Fe-nanowires (~0.08 g Fe/l) encapsuled in 
CNT. Measurements have been performed at f = 230 kHz after dispersing the CNT by 
means of human albumin in PBS (4.2g/l).
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fiber-optic temperature controller (LXT-Luxtron One). The generator can provide 
alternating magnetic fields in the frequency range of 50-1200 kHz. The data shown in 
Fig. 3 have been obtained at f = 230 kHz. Here, Fe-filled MWCNT have been 
dispersed by human albumin in PBS. The concentration was 4.2 mg/ml so that about 
0.08 mg Fe/ml can be estimated. This concentration is corroborated by analysis of 
magnetization loops. The initial slope of temperature vs. time studies was used to 
determine the specific absorption rate SAR. In agreement with previous data [33], 
values of SARFe < 100 W/gFe were found in the field range below ~20 kA/m2 which is 
applicable for medical treatment. We emphasize, however, that the presented first 
studies did not yet elucidate the actual dissipative mechanism. Detailed information 
about the magnetisation reversal will help to optimize e.g. the geometrical 
dimensions of the Fe-nanowires in order to achieve improved switching behaviour. 
 
In addition to a magnetic field induced thermal ablation described in detail above, 
CNT are also feasible for near-infrad (NIR) light based hyperthermia. This method 
applies the fact that biological systems are transparent to light in the NIR regime of 
0.7-1.1 μm wavelength while the strong absorbance renders single-walled CNT for 
hyperthermia agents in living cells [11,65,66]. Focused heat transduction and photo-
ablative destruction of kidney cancer cells has also been shown for multi-walled CNT 
if being nitrogen doped [67]. Although NIR light is capable of passing through several 
centimetres of tissue, its interaction with biological matter is by far larger than of 
magnetic fields and the penetration depth is much smaller. For efficient heat transfer 
to deep tissue and in order to avoid parasitic heating effects in surrounding tissue 
magnetic agents hence seem to be advantageous. 
 
 
5. Temperature control by NMR on filled CNT 
Accurate control of the tissue temperature is mandatory in any hyperthermia 
approach. Currently, in the clinical treatments, temperature is controlled by a 
clinician's intervention by placing thermocouples or fiber-optical thermometers into 
the tumor in combination with computer modelling later on. Any model, however, 
demands estimates of the tissue properties, blood perfusion rate and other dynamic 
properties [68]. Instead, a continuous non-invasive temperature monitoring appears 
to be advantageous not only for hyperthermia treatment. Magnetic resonance (MR) 
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thermometry based on a temperature-dependent proton resonance frequency shift of 
the water molecule provides temperature control in addition to a good spatial 
localization, thereby allowing for accurate target identification in ultrasound thermal 
therapy [69]. However, large doses of unshielded magnets which are present in 
nanoparticle-based hyperthermia introduce magnetic field inhomogeneities that 
reduce MRI contrastivity based on the proton relaxation-weighted image and prevent 
proton-based MR thermometry. 
 
A promising approach for a non-invasive in-vivo temperature control relies on the use 
of a nanoscaled thermometer, which consists of a CNT and a filling material with 
strongly temperature dependent NMR parameters. In particular, the filling material 
might exhibit strong T-dependencies of the spin-lattice or the spin-spin relaxation, 
resonance frequency, dipolar or scalar couplings, and electrical quadrupole coupling 
at 310-350 K (ca. 20-60 °C) so that temperature detection is possible with high 
accuracy (<0.1 degree). Due to the protecting carbon shell, the number of materials 
which can be used for temperature sensoring without toxic adverse effects strongly 
increases. On the other hand, the container feature of CNT might, in principle, allow 
simultaneous filling of CNT with a temperature sensor and another probe such as a 
ferromagnet (=heater), thereby combining different functionalities in one kind of CNT 
(Fig. 1). 
Up to know, the more simple system has been studied, where only the temperature 
sensor is encapsulated in CNT [53]. Many alkali and cuprous halides are known to 
show pronounced temperature dependencies of NMR parameters. From a family of 
these compounds monovalent cuprous iodide (CuI) turned out to be most suited. 
Here, both the copper and iodine nuclei have NMR active isotopes with a high 
natural abundance. 
 
The synthesis of CuI filled CNT was based on pristine nanotubes consisting from 10 
to 40 carbon layers with inner diameters between 5 and 20 nm. For filling with CuI, 
CNT were opened using thermal and acid treatment in combination with sonication. 
The opened CNT were grinded in a mortar gently and put in a silica glass ampoule 
together with CuI (Aldrich 99.99%) in excess. The ampoule was sealed under 
vacuum (10-3 Torr) and heated at 600°C for 24h. At this temperature CuI is 
completely sublimated and transported into the opened CNT thanks to the capillarity 
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effect. The resultant material was examined by transmission electron microscopy 
(TEM and HRTEM), X-ray diffraction analysis and energy dispersive X-ray analysis 
(EDX) and identified as CNT filled to 80 % with single crystalline cuprous iodide. 
Although both 63Cu and 127I nuclear isotopes possess a quadrupole moment, in CuI 
copper and iodine atoms each are surrounded tetrahedrally by four atoms of the 
opposite kind. This leads to a vanishing quadrupolar coupling. Therefore only the 
resonance frequencies, linewidths and relaxation times can be considered as 
 
 
Fig. 4: Temperature dependencies of 127I, 35Cl and 63Cu nuclear magnetic resonance 
parameters measured on CuI- and AgCl-filled CNT. (a) Nuclear magnetic resonance 
frequency. (b) Nuclear spin-lattice relaxation rate. The symbols present the 
experimental data. Solid lines are the fit (see the text). 
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temperature indicators. The NMR measurements were done in a standard solid state 
NMR spectrometer in the external magnetic field of 7.05 T. Both 63Cu and 127I NMR 
spectra obtained from the Fourier transformed echo signals represented a single 
resonance line. The spin-lattice relaxation T1 was measured employing an inversion 
recovery pulse sequence. The obtained decay of 63Cu and 127I longitudinal 
magnetisation was analyzed following a standard equation for the spin I = 3/2 and I = 
5/2, correspondingly. In both cases the magnetisation curves followed a simple 
exponential form characterized by a single spin-lattice relaxation time. 
 
The analysis of the 63Cu NMR spectra reveals insignificant changes in the resonance 
frequency in the relevant temperature range, while the resonance frequencies 
measured on the 127I nucleus indicate a stronger dependence on temperature (Fig. 
4a). Such behaviour is explained by lattice effects which include both the lattice 
vibration and the lattice expansion. The 127I NMR frequency data are well fitted with a 
linear function over the whole temperature range studied. Thus, at first glance, the 
127I resonance frequency might be used as a measure for the temperature 
determination. A relative small slope of this function leads, however, to an error of 15 
K in temperature determination. Therefore the usage of this parameter for an 
accurate temperature control is not reasonable. Furthermore, the spectral linewidths 
at half maximum have been analyzed for both nuclei and were found to be constant 
at temperatures below 320 K. Thus, also the linewidths could be ruled out to serve as 
a temperature control parameter. 
 
The temperature dependence of the 127I spin-lattice relaxation rates T1-1 is presented 
in Fig. 4b. The 63Cu T1-1 dependence is similar but much smaller compared to the 127I 
data. The T1-1 dependencies for both nuclei are found to be in very good agreement 
with the law T1-1 ~ T2 that is expected for a Raman two-phonon quadrupolar process. 
[70]. This behaviour is observed over the entire temperature range implying no 
contributions from impurities which might appear at low temperatures and from ionic 
diffusion which might be observed at high temperatures. This is consistent with the 
view that relaxation is driven by a quadrupolar mechanism in this compound [71]. 
The 127I experimental data are well fitted with a quadratic function T1-1 = a + bT + cT2, 
where fitting coefficients are a = 1, b = (7±1)*10-2 and c = (1.49±0.05)*10-3. The 
mean squared errors of the fitting coefficients provide an estimate of the accuracy of 
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the temperature determination. In the temperature range of biological interest (i.e. 
290 to 320 K) the CuI-CNT nanothermometer can indicate the temperature with an 
accuracy of 2 K by means of the spin-lattice relaxation measurement. Other Cu-
halides filled in CNT demonstrate a qualitatively similar behaviour but exhibit less 
temperature sensitivity as shown in table 1. These results, in particular those on CuI-
CNT, provide a good starting point to look for further filling materials of CNT in order 
to increase the accuracy of temperature determination. 
 
Material Nucleus dνres/dT (Hz/K) d(T1-1)/dT (Hz/K) 
CuI-CNT 
63Cu 
127I 
- 
14 
0.27 
0.86 
CuBr-CNT 
63Cu 
81Br 
19 
7 
0.15 
0.75 
CuCl2-CNT 
63Cu 
35Cl 
15 
1 
0.23 
- 
AgCl-CNT 35Cl 21 0.006 
 
Table 1: Temperature sensitivity parameters of several filled CNT. The table shows 
the filling material, the respective nucleus as well as temperature dependence of 
resonance frequency and T1-relaxation time in the temperature range of 300-320 K. 
 
Conclusions 
Due to their extraordinary physical and chemical properties carbon nanotubes reveal 
a promising potential for applications on the cellular level. Upon filling, nanoscaled 
containers are realised in which the active material is encapsulated by a protecting 
carbon shell. We describe different synthesis routes and show the structural and 
magnetic properties of CNT. In particular, the filling with magnetic material offers the 
potential for hyperthermia applications while the insertion of NMR active substances 
allows the usage as markers and sensors. This potential of carbon nanotubes for 
biomedical applications is highlighted by hyperthermia studies which prove their 
applicability for local in-situ heating. In addition we have shown that a non-invasive 
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temperature control by virtue of a carbon-wrapped nanoscaled thermometer is 
possible.  
 
A valuable extension would be spatially resolved NMR. The rapidly growing field of 
cellular and molecular MR imaging enables to visualize cells and inserted CNT in 
order to track cancer cells and to control therapies on the cellular level such as 
magnetic hyperthermia. The container feature of CNT is extensively utilized if a 
heating element (ferromagnet), a temperature sensor and a contrast agent are 
confined within the same nanocontainer. Such a combination of different 
functionalities on a nanoscale would provide simultaneous heating, temperature 
control by means of MRI and high spatial resolution of the image. Furthermore, if 
clinical usage of the static magnetic field is contra-indicated and MR imaging is no 
longer suitable then the technology proposed here addresses materials with 
temperature dependent nuclear quadrupolar resonance NQR (e.g. cuprous oxide) or 
zero-field NMR (e.g. Co-based compounds) parameters that demonstrates versatility 
of this approach for biomedical applications. The potential of CNT for biomedical 
applications becomes even more evident if their container function is exploited for 
drug delivery in magnetically functionalised and NMR labelled nanodevices. It has 
been shown that anti-cancer drugs can be inserted in CNT [54] for which purpose the 
multi-walled ones turn out to be particularly appropriate. Combing different 
functionalities in well shielded containers hence seems to be the particular 
advantage of carbon nanotubes.  
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